Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib. (Q54354951)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib. |
scientific article |
Statements
Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib (English)
B Hanfstein
V Shlyakhto
R Hehlmann
S Saussele
C Dietz
P Erben
A Fabarius
U Proetel
S Schnittger
J Schubert
H Einsele
M Hänel
J Dengler
C Falge
L Kanz
A Neubauer
M Kneba
F Stegelmann
M Pfreundschuh
C F Waller
K Spiekermann
G M Baerlocher
M Pfirrmann
J Hasford
W-K Hofmann
M C Müller
SAKK and the German CML Study Group
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference